Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 10(3): e0115638, 2015.
Article in English | MEDLINE | ID: mdl-25782009

ABSTRACT

Taishan Pinus massoniana pollen polysaccharide (TPPPS) improves cellular and humoral immune responses of animals and is a novel potential immunomodulator. However, the components of TPPPS have not been recognized. To investigate the composition of TPPPS, crude polysaccharide was obtained from Taishan P. massoniana pollen through water extraction and ethanol precipitation. Three homogeneous polysaccharide fractions (TPPPS1, TPPPS2, and TPPPS3) were purified from TPPPS by DEAE-cellulose column chromatography. The average molecular weights of the three polysaccharides were 56, 25, and 128 kDa, respectively. Results of high-performance liquid chromatography (HPLC) showed that TPPPS comprised mannose, ribose, xylose, glucuronic acid, galacturonic acid, glucose, galactose, and arabinose. The biological activity assays showed that TPPPS2 and TPPPS3 significantly promoted spleen lymphocyte proliferation, and that TPPPS3 showed better effect than TPPPS2. TPPPS3 enhanced the secretion of cytokine IL-2 and TNF, whereas TPPPS2 mainly elevated IL-2 secretion. By contrast, TPPPS1 exhibited other effects, and it induced the highest amount of NO production, thereby indicating that TPPPS1 had the best antioxidant activity. TPPPS3 at 50 µg/mL significantly inhibited the proliferation of subgroup B Avian Leukosis virus (ALV-B) through virus adsorption interference in vitro. Results indicated that TPPPS comprised three main components, among which, TPPPS1 mainly showed antioxidant effects, whereas TPPPS2 and TPPPS3 played key roles in immunomodulation, especially TPPPS3. Further studies on the use of a reasonable proportion of TPPPS1-3 may facilitate the development of an effective immunomodulator.


Subject(s)
Antioxidants/pharmacology , Antiviral Agents/pharmacology , Immunologic Factors/pharmacology , Pinus/chemistry , Pollen/chemistry , Polysaccharides/pharmacology , Animals , Antioxidants/chemistry , Antiviral Agents/chemistry , Avian Leukosis Virus/drug effects , Cell Line , Cell Proliferation/drug effects , Chick Embryo , Chickens , Cytokines/metabolism , Immunologic Factors/chemistry , Molecular Weight , Monosaccharides/analysis , Nitric Oxide/biosynthesis , Polysaccharides/chemistry , Spleen/cytology , Spleen/drug effects , Spleen/metabolism
2.
Carbohydr Polym ; 109: 71-6, 2014 Aug 30.
Article in English | MEDLINE | ID: mdl-24815403

ABSTRACT

Chicks' co-infection with immunosuppressive virus and bacteria seriously threaten the development of the poultry industry. In this study, a model was established in which chicks were injected with either subgroup B ALV (ALV-B)+Bordetella avium (B. avium), or ALV-B+B. avium+Taishan Pinus massoniana pollen polysaccharide (TPPPS), or B. avium only, or B. avium+TPPPS. The data showed that the group injected with ALV-B and B. avium exhibited significant inhibition of the immune function and therefore increased pathogenicity compared with the group injected with B. avium-only. Application of TPPPS effectively alleviated immunosuppression, and body weights increased sharply in the TPPPS groups compared with non-TPPPS groups. To some extent, TPPPS may reduce the proliferation of ALV-B. These results suggest that Pinus pollen polysaccharides are beneficial treating co-infections with immunosuppressive virus and bacteria and therefore have potential for development into safe and effective immunoregulator.


Subject(s)
Avian Leukosis/drug therapy , Bordetella Infections/veterinary , Chickens/immunology , Coinfection/veterinary , Immunologic Factors/administration & dosage , Plant Extracts/administration & dosage , Polysaccharides/administration & dosage , Animals , Avian Leukosis/blood , Avian Leukosis/immunology , Avian Leukosis Virus/immunology , Avian Proteins/blood , Bordetella Infections/blood , Bordetella Infections/drug therapy , Bordetella Infections/immunology , Bordetella avium/immunology , Chickens/microbiology , Chickens/virology , Coinfection/blood , Coinfection/drug therapy , Coinfection/immunology , Interferon-gamma/blood , Interleukin-2/blood , Pinus/chemistry , Pollen/chemistry , T-Lymphocytes/immunology
3.
Res Vet Sci ; 96(2): 260-6, 2014 Apr.
Article in English | MEDLINE | ID: mdl-24508082

ABSTRACT

In recent years, co-infection of chicken embryos with immunosuppressive viruses and bacteria occurs with an annually increasing frequency. Consequently, studies on new and safe immunoregulators, especially plant polysaccharides, have become a popular topic in the poultry industry. In the present study, we selected 300 specific pathogen free embryonated eggs, which were injected with subgroup B avian leukosis virus (ALV-B) and Bordetella avium (B. avium) to establish an artificial co-infection model. The chicks that hatched from these co-infected embryonated eggs were treated with Taishan Pinus massoniana pollen polysaccharide (TPPPS). Results indicated that relevant indices in the co-infection group were significantly lower than that in B. avium-only group. Furthermore, pathogenicity of B. avium was exacerbated, with the chicks exhibiting decreased body weights. The TPPPS groups exhibited gradual improvements in immune function and developmental status. Therefore, in terms of improving immunologic function and production performance, TPPPS could be used as immunoregulator for immune responses.


Subject(s)
Avian Leukosis Virus/immunology , Avian Leukosis/complications , Bordetella Infections/veterinary , Bordetella avium/immunology , Chickens , Poultry Diseases/microbiology , Poultry Diseases/virology , Animals , Antibodies, Bacterial/blood , Avian Leukosis/immunology , Avian Leukosis/virology , Body Weight/immunology , Bordetella Infections/complications , Bordetella Infections/immunology , Bordetella Infections/microbiology , Chick Embryo , Interferon-gamma/blood , Interleukin-2/blood , Organ Size/immunology , Pinus/immunology , Polysaccharides/immunology , Polysaccharides/therapeutic use , Poultry Diseases/immunology , Random Allocation , Specific Pathogen-Free Organisms , Viremia/veterinary , Viremia/virology
4.
Int Immunopharmacol ; 17(3): 793-8, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24076370

ABSTRACT

To study the effects of Taishan Pinus massoniana pollen polysaccharides (TPPPS) on Bordetella avium outer membrane protein A (ompA) recombinant protein vaccine, ompA was expressed, confirmed by Western blotting and mixed with TPPPS. Female BALB/c mice were randomly divided into six groups (I-VI). Groups I, II, and III were treated with TPPPS-ompA at doses of 200, 400, and 800 mg/ml, respectively. Groups IV, V, and VI were treated with Freund's adjuvant-ompA, pure ompA, and physiological saline, respectively. On days 3, 7, 14, 21, 28, 35, 42, and 49 after the first vaccination, antibody titers, interleukin-2 (IL-2) levels, peripheral blood CD4+ and CD8+ levels, and T lymphocyte proliferation rates in peripheral blood, as well as secreting-type immunoglobulin A (SIgA) levels in the duodenum, were measured. The antibody titers against ompA, IL-2, T lymphocyte proliferation rate, CD4+, and CD8+ in Group II were significantly (P<0.05) higher than those in other groups. However, little difference in SIgA content was observed among Groups I, II, and IV. These results indicated that TPPPS strengthened humoral and cellular immune response against recombinant ompA vaccine and 400 mg/ml TPPPS showed significance (P<0.05) compared with Freund's adjuvant. Therefore, TPPPS can be developed into an adjuvant for recombinant protein vaccines or plant-derived medicine for animal husbandry.


Subject(s)
Adjuvants, Immunologic/pharmacology , Bacterial Outer Membrane Proteins/immunology , Bordetella avium/immunology , Pinus/immunology , Pollen/immunology , Polysaccharides/pharmacology , Animals , Antibodies, Bacterial/immunology , Bacterial Outer Membrane Proteins/isolation & purification , Bacterial Vaccines , Cell Proliferation , Female , Immunoglobulin A/immunology , Interleukin-2/immunology , Mice , Mice, Inbred BALB C , Recombinant Proteins , T-Lymphocytes/immunology , Vaccines, Synthetic
5.
Monoclon Antib Immunodiagn Immunother ; 32(4): 295-300, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23909425

ABSTRACT

Bordetella avium is the etiologic agent of coryza and rhinotracheitis in poultry. This respiratory disease is responsible for substantial economic losses in the poultry industry. Monoclonal antibodies (MAbs) were produced against the outer membrane proteins (OMPs) of B. avium isolated from diseased chickens. BALB/c mice were immunized with the extracted B. avium OMPs. Then the splenocytes from immunized mice and SP2/0 myeloma cells were fused using PEG 4000. Three stable hybridoma clones (designated as 3G10, 4A3, and 4E8) were produced via indirect ELISA and three rounds of subcloning. The MAbs were classified as IgG1, and can recognize the 58 kDa OMP band by Western blot assays. No MAb cross-reactivity with chicken Proteus mirabilis, Escherichia coli, and Salmonella was observed. A double antibody sandwich ELISA (DAS-ELISA) was developed using the rabbit polyclonal antibodies as the capture antibody and MAb 4A3 as the detection antibody. Under the DAS-ELISA, the minimum detectable concentration of B. avium was 1 × 10(4) CFU/mL, and no cross-reactivity occurred with chicken Proteus mirabilis, Escherichia coli, and Salmonella. Results showed that the DAS-ELISA has good sensitivity and specificity. Clinical application showed the DAS-ELISA was more sensitive than the plate agglutination test. This study may be used to develop a quick and specific diagnostic kit, analyze epitopes, and establish systems for typing B. avium.


Subject(s)
Antibodies, Monoclonal/immunology , Bacterial Outer Membrane Proteins/immunology , Bordetella Infections/immunology , Bordetella avium/immunology , Chickens/immunology , Hybridomas/immunology , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/isolation & purification , Antibody Formation , Antibody Specificity , Bacterial Outer Membrane Proteins/isolation & purification , Bacterial Outer Membrane Proteins/metabolism , Bordetella Infections/blood , Bordetella Infections/microbiology , Chickens/blood , Chickens/microbiology , Electrophoresis, Polyacrylamide Gel , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunization , Mice , Mice, Inbred BALB C , Rabbits , Recombinant Proteins , Sensitivity and Specificity
6.
Int Immunopharmacol ; 15(4): 661-5, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23507193

ABSTRACT

To determine the immune function of Taishan Robinia pseudoacacia Polysaccharide (TRPPS) on chickens, 240 chickens were selected as experimental animals and treated with various doses of TRPPS by hypodermic injection before immunized NDV inactivated vaccine. The results indicated that any dose of TRPPS could significantly promote the development of the immune organs, increase the quantity of leukocyte and the ratio of lymphocyte, and improve the antibody titers against Newcastle disease. Meanwhile, it also increased the magnitude of SIgA in duodenum. However, the dose of 200 mg/ml showed to be the most effective. Therefore, in terms of improving immunologic function and production performance, TRPPS could be used as a vaccine immunopotentiator for immune responses.


Subject(s)
Adjuvants, Immunologic/therapeutic use , Chickens/immunology , Newcastle Disease/prevention & control , Polysaccharides/therapeutic use , Poultry Diseases/prevention & control , Robinia/chemistry , Adjuvants, Immunologic/administration & dosage , Adjuvants, Immunologic/isolation & purification , Animals , Antibodies, Viral/blood , Disease Models, Animal , Duodenum/drug effects , Duodenum/immunology , Immunity, Humoral/drug effects , Immunity, Mucosal/drug effects , Immunoglobulin A, Secretory/immunology , Leukocyte Count , Newcastle Disease/immunology , Newcastle disease virus/immunology , Polysaccharides/administration & dosage , Polysaccharides/isolation & purification , Poultry Diseases/immunology , Vaccines, Inactivated , Viral Vaccines/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...